VANCOUVER, Washington – (COMMERCIAL THREAD) – ZoomInfo Technologies Inc. (“ZoomInfo”) announced today that its indirect subsidiaries, ZoomInfo Technologies LLC and ZoomInfo Finance Corp. (the “Issuers” and, together with ZoomInfo, the “Company”), have priced their offering for an additional aggregate principal amount of $ 300.0 million of their existing 3.875% Senior Notes. expiring in 2029 (the “Additional Notes”). The 3.875% Senior Issuer Notes due 2029 were previously issued for an aggregate principal amount of $ 350.0 million on February 2, 2021 (the “Initial Notes”). The Additional Notes and the Initial Notes will be treated as the same series for all purposes under the Indenture which governs the Initial Notes and will govern the Additional Notes. The Additional Notes will be issued at a price equal to 99.25% of their face value plus accrued interest from February 2, 2021 to the Closing Date. The Company intends to use the proceeds of the offering, together with additional term loans contracted under its existing senior credit agreement, to repay the revolving credit loans outstanding under the contract. senior credit, pay the fees and expenses incurred in connection with the transaction and the remainder for general business purposes. The offering of the additional tickets is expected to close on July 15, 2021, subject to customary closing conditions.
The Additional Notes to be offered and the collateral relating thereto have not been and will not be registered under the Securities Act of 1933, as amended (the “Securities Act”), or any securities law. state and, unless so registered, may not be offered or sold in the United States except under an exemption or in connection with a transaction not subject to registration requirements of the Securities Act and applicable state securities laws. Additional Notes are offered, by original purchasers, only to persons reasonably considered to be qualified institutional buyers under Rule 144A under the Securities Act and to non-US persons in transactions outside the United States under of Regulation S under the Securities Act. Act.
This press release is issued in accordance with Rule 135 (c) under the Securities Act, and it does not constitute an offer to sell or the solicitation of an offer to buy securities and does not constitute an offer to sell. or a solicitation of an offer. buy or sell securities in any jurisdiction in which such offering, solicitation or sale is illegal.
This press release contains “forward-looking statements” within the meaning of federal securities laws. Forward-looking statements include all statements that are not historical facts. In some cases, you can identify these forward-looking statements by using words such as “anticipate”, “believe”, “may”, “continue”, “could”, “estimate”, “expect”, “expect,” “Objective”, “intention”, “can”, “could”, “objective”, “prospect”, “plan”, “potential”, “predict”, “projection”, “seek”, “should”, “target “,” Trend “,” will “,” would “or the negative version of these or other comparable words. These forward-looking statements include any statements regarding the intended use of the proceeds from the Additional Note Offer and the closing of the Additional Note Offer. These forward-looking statements are subject to various risks, uncertainties, assumptions or changes in circumstances that are difficult to predict or quantify. Therefore, there are or will be significant factors that could cause actual results to differ materially from those shown in such statements. These factors include, but are not limited to, those described under “Risk Factors” in ZoomInfo’s annual report on Form 10-K for the fiscal year ended December 31, 2020. These factors may be updated from time to time. further in ZoomInfo’s periodic filings with the Securities and Exchange Commission (“SEC”), which can be accessed on the SEC’s website at www.sec.gov. These factors should not be construed as exhaustive and should be read in conjunction with the other caveats included in these filings. The Company assumes no obligation to publicly update or revise any forward-looking statement, whether as a result of new information, future developments or otherwise, except as required by law.